Amdocs (NASDAQ: DOX) and Infosys (NYSE:INFY) are both mid-cap computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, profitability, valuation, analyst recommendations, dividends and institutional ownership.
Amdocs pays an annual dividend of $0.88 per share and has a dividend yield of 1.4%. Infosys pays an annual dividend of $0.39 per share and has a dividend yield of 2.5%. Amdocs pays out 29.7% of its earnings in the form of a dividend. Infosys pays out 40.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Infosys has raised its dividend for 4 consecutive years. Infosys is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
This table compares Amdocs and Infosys’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a summary of current recommendations for Amdocs and Infosys, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Amdocs presently has a consensus target price of $70.17, suggesting a potential upside of 8.10%. Infosys has a consensus target price of $15.06, suggesting a potential downside of 5.32%. Given Amdocs’ stronger consensus rating and higher possible upside, analysts plainly believe Amdocs is more favorable than Infosys.
Valuation and Earnings
This table compares Amdocs and Infosys’ revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Amdocs||$3.87 billion||2.44||$436.82 million||$2.96||21.93|
|Infosys||$10.21 billion||3.56||$2.14 billion||$0.97||16.40|
Infosys has higher revenue and earnings than Amdocs. Infosys is trading at a lower price-to-earnings ratio than Amdocs, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
93.3% of Amdocs shares are held by institutional investors. Comparatively, 19.0% of Infosys shares are held by institutional investors. 15.4% of Amdocs shares are held by company insiders. Comparatively, 22.4% of Infosys shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Risk & Volatility
Amdocs has a beta of 0.52, suggesting that its share price is 48% less volatile than the S&P 500. Comparatively, Infosys has a beta of 0.69, suggesting that its share price is 31% less volatile than the S&P 500.
Infosys beats Amdocs on 10 of the 16 factors compared between the two stocks.
Amdocs Company Profile
Amdocs Limited is a provider of software and services for communications, entertainment and media industry service providers. The Company develops, implements and manages software and services associated with business support systems (BSS), operational support systems (OSS) and network operations to enable service providers to introduce new products and services, process orders, monetize data, support new business models and enhance their understanding of their customers. The Company’s segment provides software products and services. Its services include strategic business consulting, systems integration and transformation, managed services and testing. Its managed services provide multi-year, flexible and tailored business processes and applications services, including application development and maintenance, information technology (IT) and infrastructure services, testing and professional services.
Infosys Company Profile
Infosys Limited is engaged in consulting, technology, outsourcing and next-generation services. The Company, along with its subsidiaries, provides business information technology services comprising application development and maintenance, independent validation, infrastructure management, engineering services comprising product engineering and life cycle solutions and business process management; consulting and systems integration services comprising consulting, enterprise solutions, systems integration and advanced technologies; products, business platforms and solutions to accelerate intellectual property-led innovation, including Finacle, its banking solution, and offerings in the areas of Analytics, Cloud and Digital Transformation. Its segments are Financial Services and Insurance (FSI), Manufacturing and Hi-tech (MFG & Hi-TECH), Energy & utilities, Communication and Services (ECS), Retail, Consumer packaged goods and Logistics (RCL), and Life Sciences and Healthcare (LSH).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.